1. Home
  2. NEWS
  3. Joe Golemme, CFO of Porosome Therapeutics, Inc., invited to participate in the J.P. Morgan 42nd Annual Healthcare Conference 2024 (January 8-11th, 2024) in San Francisco, CA, USA.

Joe Golemme, CFO of Porosome Therapeutics, Inc., invited to participate in the J.P. Morgan 42nd Annual Healthcare Conference 2024 (January 8-11th, 2024) in San Francisco, CA, USA.

Joe Golemme, CFO of Porosome Therapeutics, Inc., invited to participate in the J.P. Morgan 42nd Annual Healthcare Conference 2024 (January 8-11th, 2024) in San Francisco, CA, USA.
Porosome Therapeutics, Inc. Academic Chairman Prof. Bhanu P. Jena to present Keynote Lecture entitled: “The Porosome Secretory Nanomachine: Discovery to Therapy”, at the International Drug Discovery Science & Technology (IDDST) Congress in Kyoto, Japan
State of Science at Porosome Therapeutics, Inc.
Porosome reconstitution therapy: A biologic rescue from cystic fibrosis (In human lung organoids and in CF mice)